ETF Home ETF List Shorted Stocks Home About

Portfolio Holdings Detail for ISIN IE00B3VWM098
Stock Name / FundiShares VII PLC - iShares MSCI USA Small Cap ESG Enhanced ETF USD Acc
IssuerBlackrock
Entity holding fund iShares VII Public Limited Company
Entity TypeUmbrella investment company with variable capital and having segregated liability between its funds
Entity LEI 549300Q7FFITMZ2PFZ28
ETF TickerCUS1(GBX) LSE
ETF TickerCUSS(USD) LSE
ETF TickerSXRG(EUR) F
ETF TickerCSUSS.MI(EUR) CXE
ETF TickerCSUSSz(USD) CXE
ETF TickerCUSS.LS(USD) CXE
ETF TickerCSUSS(EUR) ETF Plus
ETF TickerCUS1.L(GBP) LSE
ETF TickerCUSS.L(GBP) LSE

Holdings detail for KNSA

Stock NameKiniksa Pharmaceuticals Ltd
TickerKNSA(USD) NASDAQ
TYPECommon Stock
CountryUSA
ISINBMG5269C1010

Show aggregate KNSA holdings

News associated with KNSA

7 Biotech Stocks Trading At 52-Week Highs - Can The Rally Continue?
(RTTNews) - Patience is a virtue - important in all aspects of life, and especially crucial when it comes to investing. As trading expert Steve Burns once said, "Much of our trading comes down to a battle between our patience and our impulses." - 2025-09-15 03:55:16
ALNY/RHHBY's Zilebesiran to Enter Phase III After Third Phase II Win
Alnylam and Roche report positive phase II KARDIA-3 results for zilebesiran in high-risk hypertension patients, fueling momentum for a phase III study. - 2025-09-01 11:50:00
Kiniksa Pharmaceuticals International (NASDAQ:KNSA) Sets New 52-Week High After Strong Earnings
Kiniksa Pharmaceuticals International, plc (NASDAQ:KNSA – Get Free Report)’s share price hit a new 52-week high during mid-day trading on Tuesday following a stronger than expected earnings report. The company traded as high as $31.92 and last traded at $30.13, with a volume of 203102 shares. The stock had previously closed at $27.04. The company […] - 2025-07-31 02:25:08
Kiniksa Pharmaceuticals International (NASDAQ:KNSA) Given New $54.00 Price Target at Jefferies Financial Group
Kiniksa Pharmaceuticals International (NASDAQ:KNSA – Free Report) had its price target upped by Jefferies Financial Group from $45.00 to $54.00 in a report released on Tuesday morning,Benzinga reports. The firm currently has a buy rating on the stock. KNSA has been the subject of several other reports. Wells Fargo & Company raised their target price […] - 2025-07-30 04:46:46
Wealth Enhancement Advisory Services LLC Makes New Investment in Kiniksa Pharmaceuticals International, plc (NASDAQ:KNSA)
Wealth Enhancement Advisory Services LLC purchased a new position in shares of Kiniksa Pharmaceuticals International, plc (NASDAQ:KNSA – Free Report) in the 1st quarter, HoldingsChannel reports. The firm purchased 13,564 shares of the company’s stock, valued at approximately $301,000. Several other large investors also recently modified their holdings of KNSA. Bank of New York Mellon […] - 2025-07-09 05:07:41
Kiniksa Pharmaceuticals International (NASDAQ:KNSA) Upgraded to “Buy” at Wall Street Zen
Wall Street Zen upgraded shares of Kiniksa Pharmaceuticals International (NASDAQ:KNSA – Free Report) from a hold rating to a buy rating in a research report report published on Sunday. Several other equities analysts have also recently commented on KNSA. Jefferies Financial Group raised their price target on shares of Kiniksa Pharmaceuticals International from $40.00 to […] - 2025-07-07 03:22:59
Asset Management One Co. Ltd. Buys New Shares in Kiniksa Pharmaceuticals International, plc (NASDAQ:KNSA)
Asset Management One Co. Ltd. bought a new stake in shares of Kiniksa Pharmaceuticals International, plc (NASDAQ:KNSA – Free Report) in the 1st quarter, HoldingsChannel reports. The institutional investor bought 1,860 shares of the company’s stock, valued at approximately $41,000. Several other large investors have also recently bought and sold shares of the stock. GAMMA […] - 2025-07-02 04:44:57
Kiniksa Pharmaceuticals (NASDAQ:KNSA) Trading Down 5.4% After Insider Selling
Kiniksa Pharmaceuticals, Ltd. (NASDAQ:KNSA – Get Free Report)’s share price traded down 5.4% during trading on Thursday after an insider sold shares in the company. The stock traded as low as $28.44 and last traded at $28.60. 434,756 shares changed hands during trading, a decline of 14% from the average session volume of 508,421 shares. […] - 2025-06-13 02:19:05
26,808 Shares in Kiniksa Pharmaceuticals, Ltd. (NASDAQ:KNSA) Bought by Squarepoint Ops LLC
Squarepoint Ops LLC acquired a new position in shares of Kiniksa Pharmaceuticals, Ltd. (NASDAQ:KNSA – Free Report) during the 4th quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm acquired 26,808 shares of the company’s stock, valued at approximately $530,000. Other large investors have also recently added to […] - 2025-06-04 05:04:47
Bank of America Corp DE Has $4.27 Million Stock Holdings in Kiniksa Pharmaceuticals, Ltd. (NASDAQ:KNSA)
Bank of America Corp DE increased its holdings in shares of Kiniksa Pharmaceuticals, Ltd. (NASDAQ:KNSA – Free Report) by 2.2% in the 4th quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund owned 215,772 shares of the company’s stock after buying an additional 4,654 shares during […] - 2025-05-30 04:31:00
Lazard Asset Management LLC Buys Shares of 3,098 Kiniksa Pharmaceuticals, Ltd. (NASDAQ:KNSA)
Lazard Asset Management LLC acquired a new position in shares of Kiniksa Pharmaceuticals, Ltd. (NASDAQ:KNSA – Free Report) in the fourth quarter, according to its most recent Form 13F filing with the SEC. The firm acquired 3,098 shares of the company’s stock, valued at approximately $61,000. Several other large investors have also recently made changes […] - 2025-05-26 04:50:58
BNP Paribas Financial Markets Sells 19,446 Shares of Kiniksa Pharmaceuticals, Ltd. (NASDAQ:KNSA)
BNP Paribas Financial Markets cut its holdings in Kiniksa Pharmaceuticals, Ltd. (NASDAQ:KNSA – Free Report) by 10.1% in the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 173,480 shares of the company’s stock after selling 19,446 shares during the period. BNP Paribas […] - 2025-05-15 05:36:54
Tower Research Capital LLC TRC Grows Stock Holdings in Kiniksa Pharmaceuticals, Ltd. (NASDAQ:KNSA)
Tower Research Capital LLC TRC lifted its position in Kiniksa Pharmaceuticals, Ltd. (NASDAQ:KNSA – Free Report) by 117.1% during the fourth quarter, Holdings Channel reports. The institutional investor owned 8,483 shares of the company’s stock after buying an additional 4,575 shares during the quarter. Tower Research Capital LLC TRC’s holdings in Kiniksa Pharmaceuticals were worth […] - 2025-05-07 05:32:54
Invesco Ltd. Sells 41,380 Shares of Kiniksa Pharmaceuticals, Ltd. (NASDAQ:KNSA)
Invesco Ltd. reduced its stake in shares of Kiniksa Pharmaceuticals, Ltd. (NASDAQ:KNSA – Free Report) by 74.6% during the fourth quarter, Holdings Channel reports. The institutional investor owned 14,108 shares of the company’s stock after selling 41,380 shares during the quarter. Invesco Ltd.’s holdings in Kiniksa Pharmaceuticals were worth $279,000 at the end of the […] - 2025-05-05 05:00:54
Wells Fargo & Company MN Has $417,000 Position in Kiniksa Pharmaceuticals, Ltd. (NASDAQ:KNSA)
Wells Fargo & Company MN increased its holdings in shares of Kiniksa Pharmaceuticals, Ltd. (NASDAQ:KNSA – Free Report) by 54.7% in the fourth quarter, HoldingsChannel reports. The firm owned 21,102 shares of the company’s stock after buying an additional 7,463 shares during the period. Wells Fargo & Company MN’s holdings in Kiniksa Pharmaceuticals were worth […] - 2025-05-05 04:22:58
Kiniksa Pharmaceuticals (NASDAQ:KNSA) Trading Up 4.9% Following Strong Earnings
Kiniksa Pharmaceuticals, Ltd. (NASDAQ:KNSA – Get Free Report)’s stock price was up 4.9% during mid-day trading on Wednesday after the company announced better than expected quarterly earnings. The company traded as high as $27.15 and last traded at $27.15. Approximately 869,131 shares were traded during mid-day trading, an increase of 83% from the average daily […] - 2025-05-01 04:26:57
Kiniksa Pharmaceuticals (NASDAQ:KNSA) Shares Gap Up After Strong Earnings
Kiniksa Pharmaceuticals, Ltd. (NASDAQ:KNSA – Get Free Report)’s stock price gapped up before the market opened on Tuesday following a stronger than expected earnings report. The stock had previously closed at $21.47, but opened at $22.55. Kiniksa Pharmaceuticals shares last traded at $25.01, with a volume of 81,859 shares trading hands. The company reported $0.11 […] - 2025-05-01 02:18:54
Kiniksa Pharmaceuticals (NASDAQ:KNSA) Stock Price Expected to Rise, Jefferies Financial Group Analyst Says
Kiniksa Pharmaceuticals (NASDAQ:KNSA – Free Report) had its price objective raised by Jefferies Financial Group from $40.00 to $45.00 in a report published on Tuesday morning,Benzinga reports. Jefferies Financial Group currently has a buy rating on the stock. A number of other research firms also recently commented on KNSA. Citigroup began coverage on Kiniksa Pharmaceuticals […] - 2025-04-30 04:56:50
Legal & General Group Plc Has $816,000 Stock Holdings in Kiniksa Pharmaceuticals, Ltd. (NASDAQ:KNSA)
Legal & General Group Plc cut its stake in Kiniksa Pharmaceuticals, Ltd. (NASDAQ:KNSA – Free Report) by 18.0% during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 41,267 shares of the company’s stock after selling 9,064 shares during the quarter. Legal & General Group Plc’s […] - 2025-04-28 05:02:52
JPMorgan Chase & Co. Buys 277,827 Shares of Kiniksa Pharmaceuticals, Ltd. (NASDAQ:KNSA)
JPMorgan Chase & Co. boosted its position in Kiniksa Pharmaceuticals, Ltd. (NASDAQ:KNSA – Free Report) by 138.9% during the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 477,800 shares of the company’s stock after purchasing an additional 277,827 shares during the period. JPMorgan […] - 2025-04-15 05:08:56
Wellington Management Group LLP Buys 22,096 Shares of Kiniksa Pharmaceuticals, Ltd. (NASDAQ:KNSA)
Wellington Management Group LLP raised its stake in Kiniksa Pharmaceuticals, Ltd. (NASDAQ:KNSA – Free Report) by 46.3% in the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 69,813 shares of the company’s stock after purchasing an additional 22,096 shares during the quarter. […] - 2025-04-14 05:27:05
Sei Investments Co. Has $834,000 Stake in Kiniksa Pharmaceuticals, Ltd. (NASDAQ:KNSA)
Sei Investments Co. trimmed its position in shares of Kiniksa Pharmaceuticals, Ltd. (NASDAQ:KNSA – Free Report) by 5.3% during the 4th quarter, HoldingsChannel reports. The firm owned 42,184 shares of the company’s stock after selling 2,354 shares during the quarter. Sei Investments Co.’s holdings in Kiniksa Pharmaceuticals were worth $834,000 at the end of the […] - 2025-04-09 04:28:48
Kiniksa Pharmaceuticals, Ltd. (NASDAQ:KNSA) Receives Average Rating of “Buy” from Analysts
Kiniksa Pharmaceuticals, Ltd. (NASDAQ:KNSA – Get Free Report) has earned an average recommendation of “Buy” from the six analysts that are covering the firm, MarketBeat reports. Six investment analysts have rated the stock with a buy rating. The average 12 month price objective among brokers that have issued ratings on the stock in the last […] - 2025-04-07 05:22:59
Principal Financial Group Inc. Sells 25,944 Shares of Kiniksa Pharmaceuticals, Ltd. (NASDAQ:KNSA)
Principal Financial Group Inc. lowered its stake in Kiniksa Pharmaceuticals, Ltd. (NASDAQ:KNSA – Free Report) by 49.1% during the 4th quarter, HoldingsChannel reports. The firm owned 26,907 shares of the company’s stock after selling 25,944 shares during the period. Principal Financial Group Inc.’s holdings in Kiniksa Pharmaceuticals were worth $532,000 as of its most recent […] - 2025-03-07 06:17:04
Y Intercept Hong Kong Ltd Purchases Shares of 13,050 Kiniksa Pharmaceuticals, Ltd. (NASDAQ:KNSA)
Y Intercept Hong Kong Ltd acquired a new stake in Kiniksa Pharmaceuticals, Ltd. (NASDAQ:KNSA – Free Report) in the 4th quarter, according to the company in its most recent filing with the SEC. The fund acquired 13,050 shares of the company’s stock, valued at approximately $258,000. A number of other institutional investors also recently modified […] - 2025-03-05 09:01:16
Kiniksa Pharmaceuticals, Ltd. (NASDAQ:KNSA) Shares Bought by China Universal Asset Management Co. Ltd.
China Universal Asset Management Co. Ltd. grew its holdings in shares of Kiniksa Pharmaceuticals, Ltd. (NASDAQ:KNSA – Free Report) by 12.9% in the fourth quarter, according to its most recent filing with the SEC. The firm owned 8,814 shares of the company’s stock after acquiring an additional 1,004 shares during the quarter. China Universal Asset […] - 2025-02-04 07:15:10

iShares VII PLC - iShares MSCI USA Small Cap ESG Enhanced ETF USD Acc KNSA holdings

DateNumber of KNSA Shares HeldBase Market Value of KNSA SharesLocal Market Value of KNSA SharesChange in KNSA Shares HeldChange in KNSA Base ValueCurrent Price per KNSA Share HeldPrevious Price per KNSA Share Held
2026-01-15 (Thursday)36,218KNSA holding increased by 5564USD 1,373,387KNSA holding increased by 160715USD 1,373,3875,564USD 160,715 USD 37.92 USD 39.56
2026-01-14 (Wednesday)30,654KNSA holding increased by 107USD 1,212,672KNSA holding increased by 33558USD 1,212,672107USD 33,558 USD 39.56 USD 38.6
2026-01-13 (Tuesday)30,547USD 1,179,114KNSA holding decreased by -76979USD 1,179,1140USD -76,979 USD 38.6 USD 41.12
2026-01-12 (Monday)30,547USD 1,256,093KNSA holding decreased by -47347USD 1,256,0930USD -47,347 USD 41.12 USD 42.67
2026-01-09 (Friday)30,547USD 1,303,440KNSA holding increased by 28714USD 1,303,4400USD 28,714 USD 42.67 USD 41.73
2026-01-08 (Thursday)30,547KNSA holding increased by 107USD 1,274,726KNSA holding decreased by -16539USD 1,274,726107USD -16,539 USD 41.73 USD 42.42
2026-01-07 (Wednesday)30,440USD 1,291,265KNSA holding decreased by -7914USD 1,291,2650USD -7,914 USD 42.42 USD 42.68
2026-01-06 (Tuesday)30,440USD 1,299,179KNSA holding increased by 49313USD 1,299,1790USD 49,313 USD 42.68 USD 41.06
2026-01-05 (Monday)30,440USD 1,249,866KNSA holding decreased by -28766USD 1,249,8660USD -28,766 USD 41.06 USD 42.005
2026-01-02 (Friday)30,440USD 1,278,632KNSA holding increased by 22982USD 1,278,6320USD 22,982 USD 42.005 USD 41.25
2025-12-31 (Wednesday)30,440USD 1,255,650KNSA holding increased by 7914USD 1,255,6500USD 7,914 USD 41.25 USD 40.99
Share price and value of shares held is calculated on the adjusted close price of each day (row). Changes between days reflect the gain/loss of the portfolio as a result of changes in the adjusted close price and changes in the holdings

Share Trades of KNSA by Blackrock for IE00B3VWM098

Show aggregate share trades of KNSA

DateActionQuantityMarket HighMarket LowLikely Trade PriceLikely Trade Value (Profit/Loss)Average Price previous trades
2026-01-15BUY5,56439.74137.020 37.292USD 207,493 28.89
2026-01-14BUY10739.69037.560 37.773USD 4,042 28.85
2026-01-08BUY10742.35541.350 41.450USD 4,435 28.64
2025-12-23SELL-10743.65042.343 42.474USD -4,545 28.06 Loss of -1,542 on sale
2025-12-03SELL-53541.55039.610 39.804USD -21,295 27.17 Loss of -6,757 on sale
2025-12-02BUY21441.60040.050 40.205USD 8,604 27.11
2025-11-25BUY2,12042.85041.000 41.185USD 87,312 26.75
2025-11-24BUY22,42542.35040.760 40.919USD 917,609 26.67
2025-11-17SELL-23141.69039.610 39.818USD -9,198 26.30 Loss of -3,122 on sale
2025-11-12SELL-2141.26540.040 40.163USD -843 26.09 Loss of -296 on sale
2025-11-06SELL-2139.37038.520 38.605USD -811 25.82 Loss of -269 on sale
2025-11-05SELL-21039.65538.220 38.364USD -8,056 25.75 Loss of -2,649 on sale
2025-11-04SELL-4239.28037.470 37.651USD -1,581 25.68 Loss of -503 on sale
2025-11-03SELL-4237.94036.560 36.698USD -1,541 25.62 Loss of -465 on sale
2025-10-28BUY6339.43042.050 41.788USD 2,633 25.36
2025-10-24SELL-2138.93039.600 39.533USD -830 25.20 Loss of -301 on sale
2025-10-15BUY12638.86039.200 39.166USD 4,935 24.67
2025-10-02BUY2137.47038.590 38.478USD 808 24.52
2025-09-30BUY4238.83039.000 38.983USD 1,637 24.35
2025-09-11BUY8437.01037.050 37.046USD 3,112 23.99
2025-08-21SELL-2133.58033.680 33.670USD -707 23.93 Loss of -205 on sale
2025-07-31BUY6330.26030.840 30.782USD 1,939 23.84
2025-06-30SELL-4227.67028.535 28.448USD -1,195 23.27 Loss of -217 on sale
2025-06-25SELL-2128.38029.230 29.145USD -612 23.17 Loss of -126 on sale
2025-06-20SELL-4228.44028.520 28.512USD -1,198 23.05 Loss of -229 on sale
2025-05-23BUY2126.89027.030 27.016USD 567 22.18
2025-05-19SELL-2126.74026.780 26.776USD -562 22.04 Loss of -100 on sale
2025-05-15SELL-6325.87025.950 25.942USD -1,634 21.97 Loss of -250 on sale
2025-05-12SELL-2126.84026.910 26.903USD -565 21.86 Loss of -106 on sale
2025-05-09SELL-2126.03027.140 27.029USD -568 21.83 Loss of -109 on sale
2025-04-30SELL-2126.97027.528 27.472USD -577 21.46 Loss of -126 on sale
2025-04-24SELL-4220.56021.235 21.168USD -889 21.43 Profit of 11 on sale
2025-04-17SELL-2120.21020.645 20.602USD -433 21.49 Profit of 19 on sale
2025-04-15SELL-6321.22021.240 21.238USD -1,338 21.50 Profit of 17 on sale
2025-04-14SELL-6320.69020.935 20.910USD -1,317 21.51 Profit of 38 on sale
2025-04-09SELL-8419.90020.160 20.134USD -1,691 21.59 Profit of 122 on sale
2025-04-07SELL-14720.28021.110 21.027USD -3,091 21.62 Profit of 88 on sale
2025-04-04SELL-21020.36021.210 21.125USD -4,436 21.64 Profit of 108 on sale
2025-03-31BUY2122.21022.655 22.611USD 475 21.63
2025-03-19SELL-4223.08023.110 23.107USD -970 21.45 Loss of -69 on sale
2025-03-14SELL-12622.61022.860 22.835USD -2,877 21.40 Loss of -181 on sale
2025-03-13SELL-4222.16022.940 22.862USD -960 21.39 Loss of -62 on sale
2025-03-12SELL-71422.50022.630 22.617USD -16,149 21.37 Loss of -887 on sale
2025-03-07SELL-4221.51022.140 22.077USD -927 21.38 Loss of -29 on sale
2025-03-06SELL-6321.27021.580 21.549USD -1,358 21.38 Loss of -11 on sale
2025-03-03SELL-2121.46022.230 22.153USD -465 21.38 Loss of -16 on sale
2025-02-28SELL-12620.28020.489 20.468USD -2,579 21.40 Profit of 117 on sale
2025-02-26SELL-2119.69020.160 20.113USD -422 21.45 Profit of 28 on sale
2025-02-25SELL-6319.72020.150 20.107USD -1,267 21.48 Profit of 87 on sale
2025-02-18BUY10519.55020.010 19.964USD 2,096 21.68
2025-02-13BUY2119.65019.680 19.677USD 413 21.80
2025-02-12BUY2119.28019.905 19.843USD 417 21.85
2025-02-11BUY6319.70019.750 19.745USD 1,244 21.90
2025-02-06BUY18920.29020.730 20.686USD 3,910 22.04
2025-01-27BUY2120.76020.780 20.778USD 436 22.52
2024-12-30BUY10519.60019.870 19.843USD 2,084 22.85
2024-12-06BUY8421.51021.560 21.555USD 1,811 22.99
2024-12-05BUY2120.98021.300 21.268USD 447 23.06
2024-12-04BUY10521.13021.250 21.238USD 2,230 23.13
2024-11-29BUY10522.08022.380 22.350USD 2,347 23.30
2024-11-27BUY8422.32022.480 22.464USD 1,887 23.39
2024-11-26BUY2122.04022.280 22.256USD 467 23.45
2024-11-21BUY10521.09021.380 21.351USD 2,242 23.78
2024-11-20BUY6321.21021.550 21.516USD 1,356 23.92
2024-11-18BUY25221.50021.520 21.518USD 5,423 24.26
2024-11-12BUY16822.99023.330 23.296USD 3,914 24.35
2024-11-08BUY10522.86023.370 23.319USD 2,448 24.45
2024-11-07BUY31523.01023.420 23.379USD 7,364 24.57
2024-11-06BUY4223.03023.170 23.156USD 973 24.69
2024-10-31BUY2122.59023.200 23.139USD 486 25.97
Market high and low price is on the date.

* (if shown) = market close price used not a projected price. This is used when we do not have market data available to calculate a projection

The likely trade price/value is our estimate on the likely price the trade took place at and is not the actual trade price. The likely LOSS/GAIN is our estimate. Where a profit/loss value is shown in the Likely Trade Value column, this is derived from matching trades between periods eg the most recent previous BUY is matched with the SELL for the same number of shares and the difference between the likely BUY price and likely SELL price is calculated. Where a profit or loss is shown in the Average Price of Previous Trades column, this is dervied using the likely trade price compared to the average of previous trades based on adjusted close

Shorting History of KNSA

DateShorted VolumeShort Exempt VolumeTotal Shares Traded% Shorted
2025-09-1919,510077,94425.0%
2025-09-1828,757085,33433.7%
2025-09-1726,244086,76330.2%
2025-09-1626,8220101,02626.5%
2025-09-1567,1110245,29827.4%
2025-09-1279,6520190,84941.7%
2025-09-1174,1701142,13052.2%
2025-09-1048,01211112,08742.8%
2025-09-0941,1231,000111,66736.8%
2025-09-0897,9530231,35842.3%
2025-09-0539,5860124,56331.8%
2025-09-0448,643500207,44823.4%
2025-09-0388,7660281,54031.5%
2025-09-0246,1330208,07422.2%
2025-08-2938,5000101,85337.8%
2025-08-2820,989091,86222.8%
2025-08-2738,8300158,26524.5%
2025-08-2670,40128208,70333.7%
2025-08-2530,272432117,78625.7%
2025-08-2237,5100145,25225.8%
2025-08-2130,0300136,12022.1%
2025-08-2035,0710153,76522.8%
2025-08-1946,6550149,31331.2%
2025-08-1881,2550315,15725.8%
2025-08-1581,7961179,85745.5%
2025-08-1466,783293201,79233.1%
2025-08-1379,7920256,40831.1%
2025-08-1230,6440180,54017.0%
2025-08-1162,0120161,25838.5%
2025-08-0852,8250211,25625.0%
2025-08-0791,9150237,70938.7%
2025-08-0680,91960288,64428.0%
2025-08-05183,055202545,10133.6%
2025-08-04148,6440330,97544.9%
2025-08-01163,8120494,27133.1%
2025-07-3149,4100186,22226.5%
2025-07-30158,92810,944477,71333.3%
2025-07-29272,9291,600586,61146.5%
2025-07-2890,9210231,54039.3%
2025-07-2553,5940220,49524.3%
2025-07-2444,8400142,43931.5%
2025-07-2343,1220127,25533.9%
2025-07-2256,431500146,70738.5%
2025-07-2145,8630155,87629.4%
2025-07-1880,5940198,62240.6%

The data here is derived from FINRA daily shorted trade data. The Daily Short Sale Volume is the total volume of short trades that meet certain criteria on each trade date by 6 PM ET on the trade date. The detail trade data is derived from the monthly shorted trade data which will differ in aggregate. The detail trade data is derived from the transaction level data and includes ALL trades (including exempt) and the aggregation period extends beyond 6pm.

Back to Listing

Note: All information is provided as is without warranty and should be used for indicative purposes only. You should independently check data before making any investment decision. This information is derived from third party sources and we cannot guarantee that their data is current, accurate, complete, free from defects etc and we therefore accept no responsibility for how it may be used. We accept no liability.

Copyright Market Footprint Ltd. Privacy Policy